Skip to content
healthcare.dev

Everolimus

NDC 0054-0471, Everolimus, tablet, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0471
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206133
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0471 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS.5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
0054-0471-210005404712160 TABLET in 1 BOTTLE (0054-0471-21)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cf2dd54b-7a1d-4401-9a01-75e68235e433
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0054-0471
  • NADAC price for package 00054047121

    GET /v1/drugs/nadac/00054047121

Use it

Look up 0054-0471 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0471 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0471. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.